Literature DB >> 27374406

Essential Role of the PfRh5/PfRipr/CyRPA Complex during Plasmodium falciparum Invasion of Erythrocytes.

Jennifer C Volz1, Alan Yap2, Xavier Sisquella1, Jenn K Thompson1, Nicholas T Y Lim1, Lachlan W Whitehead1, Lin Chen1, Marko Lampe3, Wai-Hong Tham2, Danny Wilson1, Thomas Nebl1, Danushka Marapana2, Tony Triglia1, Wilson Wong1, Kelly L Rogers1, Alan F Cowman4.   

Abstract

Plasmodium falciparum parasites in the merozoite stage invade human erythrocytes and cause malaria. Invasion requires multiple interactions between merozoite ligands and erythrocyte receptors. P. falciparum reticulocyte binding homolog 5 (PfRh5) forms a complex with the PfRh5-interacting protein (PfRipr) and Cysteine-rich protective antigen (CyRPA) and binds erythrocytes via the host receptor basigin. However, the specific role that PfRipr and CyRPA play during invasion is unclear. Using P. falciparum lines conditionally expressing PfRipr and CyRPA, we show that loss of PfRipr or CyRPA function blocks growth due to the inability of merozoites to invade erythrocytes. Super-resolution microscopy revealed that PfRipr, CyRPA, and PfRh5 colocalize at the junction between merozoites and erythrocytes during invasion. PfRipr, CyRPA, and PfRipr/CyRPA/PfRh5-basigin complex is required for triggering the Ca(2+) release and establishing the tight junction. Together, these results establish that the PfRh5/PfRipr/CyRPA complex is essential in the sequential molecular events leading to parasite invasion of human erythrocytes.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27374406     DOI: 10.1016/j.chom.2016.06.004

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  68 in total

1.  The PfAP2-G2 transcription factor is a critical regulator of gametocyte maturation.

Authors:  Suprita Singh; Joana M Santos; Lindsey M Orchard; Naomi Yamada; Riëtte van Biljon; Heather J Painter; Shaun Mahony; Manuel Llinás
Journal:  Mol Microbiol       Date:  2021-02-15       Impact factor: 3.501

2.  Antibody responses to the RTS,S/AS01E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique.

Authors:  Gemma Moncunill; Carlota Dobaño; Lina Sánchez; Marta Vidal; Chenjerai Jairoce; Ruth Aguilar; Itziar Ubillos; Inocencia Cuamba; Augusto J Nhabomba; Nana Aba Williams; Núria Díez-Padrisa; David Cavanagh; Evelina Angov; Ross L Coppel; Deepak Gaur; James G Beeson; Sheetij Dutta; Pedro Aide; Joseph J Campo
Journal:  NPJ Vaccines       Date:  2020-06-04       Impact factor: 7.344

Review 3.  Gliding motility powers invasion and egress in Apicomplexa.

Authors:  Karine Frénal; Jean-François Dubremetz; Maryse Lebrun; Dominique Soldati-Favre
Journal:  Nat Rev Microbiol       Date:  2017-09-04       Impact factor: 60.633

4.  Disrupting CD147-RAP2 interaction abrogates erythrocyte invasion by Plasmodium falciparum.

Authors:  Meng-Yao Zhang; Yang Zhang; Xiao-Dong Wu; Kun Zhang; Peng Lin; Hui-Jie Bian; Min-Min Qin; Wan Huang; Ding Wei; Zhao Zhang; Jiao Wu; Ruo Chen; Fei Feng; Bin Wang; Gang Nan; Ping Zhu; Zhi-Nan Chen
Journal:  Blood       Date:  2018-01-19       Impact factor: 22.113

5.  A pan-apicomplexan phosphoinositide-binding protein acts in malarial microneme exocytosis.

Authors:  Zeinab Ebrahimzadeh; Angana Mukherjee; Marie-Ève Crochetière; Audrey Sergerie; Souad Amiar; L Alexa Thompson; Dominic Gagnon; David Gaumond; Robert V Stahelin; Joel B Dacks; Dave Richard
Journal:  EMBO Rep       Date:  2019-05-16       Impact factor: 8.807

6.  Evidence against a Role of Elevated Intracellular Ca2+ during Plasmodium falciparum Preinvasion.

Authors:  Viola Introini; Alex Crick; Teresa Tiffert; Jurij Kotar; Yen-Chun Lin; Pietro Cicuta; Virgilio L Lew
Journal:  Biophys J       Date:  2018-04-10       Impact factor: 4.033

Review 7.  Antibodies against Plasmodium falciparum malaria at the molecular level.

Authors:  Jean-Philippe Julien; Hedda Wardemann
Journal:  Nat Rev Immunol       Date:  2019-08-28       Impact factor: 53.106

8.  Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions.

Authors:  Ruth O Payne; Sarah E Silk; Sean C Elias; Kazutoyo Miura; Ababacar Diouf; Francis Galaway; Hans de Graaf; Nathan J Brendish; Ian D Poulton; Oliver J Griffiths; Nick J Edwards; Jing Jin; Geneviève M Labbé; Daniel Gw Alanine; Loredana Siani; Stefania Di Marco; Rachel Roberts; Nicky Green; Eleanor Berrie; Andrew S Ishizuka; Carolyn M Nielsen; Martino Bardelli; Frederica D Partey; Michael F Ofori; Lea Barfod; Juliana Wambua; Linda M Murungi; Faith H Osier; Sumi Biswas; James S McCarthy; Angela M Minassian; Rebecca Ashfield; Nicola K Viebig; Fay L Nugent; Alexander D Douglas; Johan Vekemans; Gavin J Wright; Saul N Faust; Adrian Vs Hill; Carole A Long; Alison M Lawrie; Simon J Draper
Journal:  JCI Insight       Date:  2017-11-02

9.  A multistage antimalarial targets the plasmepsins IX and X essential for invasion and egress.

Authors:  Paco Pino; Reto Caldelari; Budhaditya Mukherjee; Juha Vahokoski; Natacha Klages; Bohumil Maco; Christine R Collins; Michael J Blackman; Inari Kursula; Volker Heussler; Mathieu Brochet; Dominique Soldati-Favre
Journal:  Science       Date:  2017-10-27       Impact factor: 47.728

10.  Antibody Combinations Targeting the Essential Antigens CyRPA, RH5, and MSP-119 Potently Neutralize Plasmodium falciparum Clinical Isolates From India and Africa.

Authors:  Hina Singh; Syed Yusuf Mian; Alok K Pandey; Sri Krishna; Gaurav Anand; K Sony Reddy; Neha Chaturvedi; Vanndita Bahl; Nidhi Hans; Man Mohan Shukla; Quique Bassat; Alfredo Mayor; Kazutoyo Miura; Praveen K Bharti; Carole Long; Neeru Singh; Virander Singh Chauhan; Deepak Gaur
Journal:  J Infect Dis       Date:  2021-06-04       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.